Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12226411 | Soluble guanylate cyclase activators for treating portal hypertension | Judith Maria Ertle, Leo John SEMAN | 2025-02-18 |
| 11690848 | Alkoxy pyrazoles as soluble guanylate cyclase activators | Judith Maria Ertle, Ruediger Streicher | 2023-07-04 |
| 8772469 | Synthetic double-stranded oligonucleotides for specific inhibition of gene expression | Eugen Uhlmann, Niki Gunkel, Sandra Neumann | 2014-07-08 |
| 7910602 | Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1 | Henning Steinhagen, Kurt Ritter, Bernard Pirard, Kirsten BJERGARDE, Marcel Patek +2 more | 2011-03-22 |
| 7635769 | Oligoribonucleotide derivatives for specific inhibition of gene expression | Eugen Uhlmann, Niki Gunkel, Sandra Neumann | 2009-12-22 |
| 7514423 | Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases | Stefan Schafer, Wolfgang Linz, Markus Bleich | 2009-04-07 |
| 7279286 | High-throughput-assay with high sensitivity for measuring of the activity of β-adrenergic receptor kinase and for determining the impact of test substances on such activity | Aimo Kannt, Antje Pommereau, Harald Thuering, Martin Oppermann | 2007-10-09 |
| 7169612 | Use of EDG2 receptor in an animal model of heart failure | Evi Kostenis, Paulus Wohlfart, Kai Rosport, Andreas Bueltmann, Christine Baumgartner +2 more | 2007-01-30 |
| 6930103 | Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases | Stefan Schafer, Wolfgang Linz, Markus Bleich | 2005-08-16 |